FDA approves Dupilumab for atopic dermatitis in teenagers
미 FDA 는 사춘기 아이들의 습진 치료에 dupilumab를 쓸 수 있다고 허가 했다
The Food and Drug Administration approved Dupixent (dupilumab) for the treatment of moderate-to-severe atopic dermatitis in younger patients. The article notes that the drug was previously approved for adults in 2017.
FDA Approves Dupilumab for Atopic Dermatitis in Teenagers
The US FDA has approved dupilumab for the treatment of eczema in adolescents.
The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of moderate-to-severe atopic dermatitis in younger patients. The article notes that the drug was previously approved for adults in 2017.
drleepediatrics.com
1/17/2026